**Core Concept**
Long-acting insulins are a class of insulin analogs designed to provide a steady and prolonged action, typically lasting 24 hours or more, to help control blood glucose levels in patients with diabetes. These insulins are often used in basal insulin regimens to provide background insulin levels throughout the day.

**Why the Correct Answer is Right**
Long-acting insulins, such as glargine (A) and detemir (B), have a unique molecular structure that allows them to be absorbed slowly and evenly, providing a flat and sustained action over an extended period. This is achieved through the addition of fatty acid chains or other modifications to the insulin molecule, which slow down its absorption and prolong its action.

**Why Each Wrong Option is Incorrect**
**Option A:** Glargine is a long-acting insulin analog, derived from human insulin, with a unique molecular structure that allows it to be absorbed slowly and evenly.
**Option B:** Detemir is another long-acting insulin analog, with a fatty acid chain attached to the B-chain, which slows down its absorption and prolongs its action.
**Option C:** Lente insulin is an intermediate-acting insulin, with a peak action of around 4-12 hours, but it is not considered a long-acting insulin.

**Clinical Pearl / High-Yield Fact**
When choosing a basal insulin, it's essential to consider the duration of action and the patient's lifestyle, as long-acting insulins can provide a steady background insulin level throughout the day, but may not be suitable for patients with varying insulin needs.

**Correct Answer: C. Lente insulin is an intermediate-acting insulin, with a peak action of around 4-12 hours, but it is not considered a long-acting insulin.**